Samir S Parekh (Samir Parekh)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Multiple Myeloma

Intellectual Disability

Top Venues

JCO precision oncology

Communications biology

Blood cancer discovery

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Santiago Thibaud, Ryan L Subaran, Scott Newman, Alessandro Lagana, David T Melnekoff, Saoirse Bodnar, Meghana Ram, Zachry Soens, William Genthe, Tehilla E Brander, Tarek H Mouhieddine, Oliver Van Oekelen, Jane Houldsworth, Hearn Jay Cho, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Ajai Chari, Erin Laverne Moshier, Sundar Jagannath, Samir S Parekh, Kenan Onel
Multiple Myeloma Risk and Outcomes are Associated with Pathogenic Germline Variants in DNA Repair Genes. Blood cancer discovery (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Mark M Stevens, Robert J Kimmerling, Selim Olcum, Madeleine Vacha, Rachel LaBella, Anthony Minnah, Katelin Katsis, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Joseph Criscitiello, Ruben Niesvizky, Noopur S Raje, Andrew R Branagan, Amrita Y Krishnan, Sundar Jagannath, Samir S Parekh, Adam S Sperling, Cara A Rosenbaum, Nikhil C Munshi, Marlise R Luskin, Anobel Tamrazi, Clifford A Reid
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of Malignancies. JCO precision oncology 8 (2024)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie, Alex Lieberman-Cribbin, Hearn Jay Cho, Samir S Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Santiago Thibaud, Sundar Jagannath, Ajai Chari
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies. Blood cancer discovery (2023)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 6 (1) (2023)
Paula Restrepo, Sherry Bhalla, Yogita Ghodke-Puranik, Adolfo Aleman, Violetta V Leshchenko, David T Melnekoff, Sarita Agte, Joy J Jiang, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Sundar Jagannath, Christopher J Walker, Yosef Landesman, Alessandro Laganà, Samir S Parekh
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma. JCO precision oncology 6 (2022)
Robert J Kimmerling, Mark M Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A Criscitiello, Ruben Niesvizky, Marlise R Luskin, Samir S Parekh, Cara A Rosenbaum, Anobel Tamrazi, Clifford A Reid
A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. Communications biology 5 (1) (2022)
Alessandro Lagana, Samir S Parekh
(Distinct) origins of IgM myeloma. Blood 138 (20) (2021)
Oliver Van Oekelen, Adolfo Aleman, Bhaskar Upadhyaya, Sandra Schnakenberg, Deepu Madduri, Somali Gavane, Julie Teruya-Feldstein, John F Crary, Mary E Fowkes, Charles B Stacy, Seunghee Kim-Schulze, Adeeb Rahman, Alessandro Laganà, Joshua D Brody, Miriam Merad, Sundar Jagannath, Samir S Parekh
Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature medicine (2021)
Sherry Bhalla, David T Melnekoff, Adolfo Aleman, Violetta V Leshchenko, Paula Restrepo, Jonathan J Keats, Kenan Onel, Jeffrey R Sawyer, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Joel T Dudley, Sundar Jagannath, Alessandro Lagana, Samir S Parekh
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications. Science advances 7 (47) (2021)